)
Investor Relations14 Oct 2025
Boost Your Earnings Season Strategy With Real‑Time Alerts
Quartr Pro provides real time alerts, trend analysis and live coverage, giving analysts and investors instant insights to act faster in earnings.
Sernova Biotherapeutics (SVA) investor relations material
Sernova Biotherapeutics Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary14 Sep, 2025
Executive summary
Focused on regenerative medicine, advancing the Cell Pouch Bio-hybrid Organ for chronic diseases, with lead programs in type 1 diabetes, hypothyroidism, and hemophilia A.
Phase 1/2 clinical trial in type 1 diabetes shows 8 of 12 patients achieving insulin independence, with sustained results in some cases over 4 years.
Strategic partnerships with Evotec (iPSC-based islet clusters) and Eledon Pharmaceuticals (immunosuppressive agent) support pipeline development.
FDA IND approval received for hypothyroidism program; preclinical progress in hemophilia A.
Financial highlights
Net loss for the nine months ended July 31, 2025 was $13.5 million, a significant decrease from $27.2 million in the prior year period.
Research and development expenses decreased by $13.3 million year-over-year, reflecting cost-saving measures and reduced activity in the iPSC program.
General and administrative expenses also declined by $1.1 million year-over-year due to lower legal, professional, and investor relations costs.
Cash at July 31, 2025 was $84 thousand, with a working capital deficit of $23.9 million.
Financing activities provided $4.8 million in the nine months ended July 31, 2025, mainly from a $4 million loan and $1.2 million in debenture financing.
Outlook and guidance
Material uncertainty exists regarding the ability to continue as a going concern; additional funding is required before the end of September 2025 to meet obligations and continue R&D.
Management is actively seeking new financing through equity, loans, or strategic alliances.
Planned cost reductions and deferral of expenditures until sufficient funding is secured.
Update on vendor payment plan renegotiations?
Expected impact of Tegoprubart in T1D trial?
What is the impact of R&D outsourcing?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Sernova Biotherapeutics earnings date
Q4 202527 Jan, 2026
Next Sernova Biotherapeutics earnings date
Q4 202527 Jan, 2026
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Edge3 Oct 2025
Epiroc: A Culture of Moving Mountains
From automation to electrification, Swedish industrial giant Epiroc is leading a transformation in how the world mines.
)
Company Research22 Sep 2025
Moody's: Shaping Global Credit
Explore Moody's evolution from publishing manuals to becoming a giant in credit ratings, guiding issuers, investors, and regulators worldwide.
Frequently asked questions
Sernova Corp is a biotechnology company focused on developing cell therapy solutions for the treatment of chronic diseases, including diabetes, hemophilia, and thyroid disorders. The company’s lead technology, the Cell Pouch System, is an implantable device designed to house therapeutic cells that can produce essential proteins or hormones, potentially offering a functional cure for diseases such as type 1 diabetes. The company is headquartered in London, Canada, and its shares are listed on the TSX and OTCQB.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage